Patent · US Active

RNAi-mediated inhibition of histamine receptor H1-related conditions

US9206428B2 · kind B2 · utility

1Cited by

3References

17Claims

0Family size

Assignee

Arrowhead Research Corporation · US

Inventors

John M. Yanni · Burleson, US
Jon E. Chatterton · Fort Worth, US
Daniel A. Gamache · Arlington, US
Steven T. Miller · Arlington, US

Key dates

Filing date	Nov 22, 2013
Grant date	Dec 8, 2015
Priority date	—
Expiry date	Nov 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/141
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

RNA interference is provided for inhibition of histamine receptor H1 mRNA expression, in particular, for treating patients having an HRH1-related condition or at risk of developing an HRH1-related condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, or allergy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.